Intuitive Surgical price target raised to $320 from $265 at Argus

Argus analyst David Toung raised the firm’s price target on Intuitive Surgical to $320 from $265 and keeps a Buy rating on the shares. The analyst anticipates higher surgical volume to drive increased utilization of existing da Vinci units, which should in turn boost hospitals’ orders for additional units. Toung adds that Intuitive Surgical’s da Vinci devices have "strong growth prospects" in relatively underpenetrated European and Asia- Pacific markets.